Literature DB >> 3978237

The vasorelaxant action of parathyroid hormone fragments on isolated rat tail artery.

P K Pang, M C Yang, R Shew, T E Tenner.   

Abstract

Previous studies have demonstrated that parathyroid hormone (PTH) and its 1-34 amino terminal fragment possess a hypotensive action in vivo which appeared to be direct and dose-dependent. However, attempts to demonstrate the phenomenon in isolated vascular tissue have been minimally successful at best. The present study reports that bovine PTH-(1-34) can relax isolated rat tail artery helical strips precontracted by either arginine vasopressin, depolarizing concentrations of potassium chloride, or norepinephrine. The phenomenon occurs in a dose-dependent manner and is not dependent upon the presence of the endothelial lining of the vessels. These studies support the hypothesis that bovine PTH-(1-34) produces a direct vasorelaxant action mainly in small arteries.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3978237

Source DB:  PubMed          Journal:  Blood Vessels        ISSN: 0303-6847


  4 in total

1.  The vasodilator action of parathyroid hormone fragments on isolated perfused rat kidney.

Authors:  M J Musso; M Barthelmebs; J L Imbs; M Plante; C Bollack; J J Helwig
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-08       Impact factor: 3.000

2.  Mechanisms of vasodilation to PTH 1-84, PTH 1-34, and PTHrP 1-34 in rat bone resistance arteries.

Authors:  T Benson; T Menezes; J Campbell; A Bice; B Hood; R Prisby
Journal:  Osteoporos Int       Date:  2016-01-05       Impact factor: 4.507

3.  Parathyroid Hormone's Acute Effect on Vasodilatory Function.

Authors:  P Farahnak; L Lind; K Mattala; I-L Nilsson
Journal:  Clin Med Insights Endocrinol Diabetes       Date:  2010-04-26

4.  Short-term intermittent PTH 1-34 administration and bone marrow blood vessel ossification in Mature and Middle-Aged C57BL/6 mice.

Authors:  Seungyong Lee; Rhonda D Prisby
Journal:  Bone Rep       Date:  2018-12-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.